FutureSight is seeking a Co-Founder & CEO to lead Veriflow, an AI-native denial management and revenue recovery venture currently being built at our studio. This is a co-founder partnership with meaningful founder equity, not a salaried executive role.
We are entering a $16B+ Total Addressable Market with a gaping $ 7.5B–$10B whitespace, targeting the highly underserved mid-market segment. Currently, 30–40% of denied medical claims go uncontested because practices lack the staff and capital to contest them. This systemic failure leaves between $50,000 and $300,000 in legally earned revenue permanently abandoned at each practice every year.
Veriflow AI resolves denied and aged claims end-to-end, embedding outcome-based contingency pricing—meaning practices pay zero upfront, and we only take a cut of the dollars we successfully recover, for our target ideal customer profile (practices with $80K+ in annual recoverable claims).
Market ContextWe didn’t just read market reports; we spent weeks interviewing billing managers, practice owners, revenue cycle leaders at health systems, and even digital operations leaders at major insurance companies. The dysfunction we uncovered is staggering, creating a massive opportunity for a disruptor:
- The pain is so severe, practices are building their own tech: The frustration of payer opacity is so deep that medical billers are hiring part-time software engineers to build in-house robotic process automation (RPA) scrapers just to check claim statuses.
- Massive, emotional write-offs: Staff carry immense guilt over these administrative losses. One small-practice assistant admitted, "I feel like we probably had to write off probably close to a million dollars" simply because they couldn't keep up with the manual follow-ups.
- The "Payer-Side Inversion" Opportunity: We discovered that insurance companies are drowning in the exact same claims dysfunction they generate. One major payer we interviewed reported a backlog of 31,000 contested claims that consumed 80% of their staff's operational capacity, forcing emergency hires just to manage the disputes.
- The Competition is Distracted: Well-funded Tier-1 competitors are charging $15K+ upfront licensing fees and fighting over enterprise health systems. The competitive window to capture the mid-market with a contingency-priced autonomous agent is wide open.
FutureSight is a leading venture studio that co-creates world-class software companies with values-driven entrepreneurs from inception to exit. We are a team of founders, operators and designers with experience successfully bringing software to market at scale.
You’ll co-create with a proven studio team, including:
- John Carbrey – 4x founder, bootstrapped to $100M ARR
- Joshua Auslander – Seasoned CFO and strategic advisor with $200M aggregate exits
- Alan Smith – Globally recognized early stage validation expert, 24 products launched, an exit, 5M+ books sold
- Prathna Ramesh – Early-stage investor and capital strategy advisor
- Founder equity with meaningful ownership from inception
- Pre-seed capital committed by FutureSight for early hires and MVP development, with potential for follow-on funding
- Studio resources, including embedded design, engineering, growth, and fundraising support from day one
- Investor and advisor network across healthtech and early-stage capital markets
- A true co-creation model in which you operate as CEO with the studio as your partner
As Co-Founder & CEO, you will set the venture's direction and lead its execution.
- Strategy — Refine the ICP, pricing model, and product positioning
- Customer Development — Lead pilots with practice owners and revenue cycle leaders, convert them to paid engagements, and build the go-to-market motion
- Product — Partner with the FutureSight product and engineering team to ship V1 and iterate on user feedback
- Capital — Lead the seed raise, supported by FutureSight's network and traction
- Team — Recruit and lead the founding team, and establish the cultural foundation of the company
- Domain & Workflow Depth: You have direct exposure to healthcare revenue cycle, medical billing, or denial management. You understand the nuanced differences in denial codes, know why administrative denials (like credentialing gaps) are uniquely painful, and intuitively understand the fragmented systems (e.g., Tebra, eClinicalWorks, Availity) that billers are forced to use
- Previous founding experience at a venture-backed company
- Demonstrated success in B2B SaaS go-to-market, including sales and customer engagement
- Fundraising fluency, with the ability to develop investor narratives and close capital
- Proven ability to attract, develop, and retain top talent
- Clear-eyed understanding of the risks and demands of co-founding a venture-backed company
Please submit your resume, LinkedIn profile, and a brief note on why this venture aligns with your goals as a founder. We will move quickly for the right candidate.
FutureSight is committed to diversity, equity, and inclusion. We welcome applicants of all backgrounds and experiences.
